Compare GNL & LKFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GNL | LKFT |
|---|---|---|
| Founded | 2011 | N/A |
| Country | United States | Belgium |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.0B |
| IPO Year | 2011 | 2007 |
| Metric | GNL | LKFT |
|---|---|---|
| Price | $9.15 | $28.77 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $9.67 | N/A |
| AVG Volume (30 Days) | ★ 2.4M | 247.2K |
| Earning Date | 05-05-2026 | N/A |
| Dividend Yield | ★ 7.98% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $495,286,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.95 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.48 | $25.68 |
| 52 Week High | $10.04 | $30.91 |
| Indicator | GNL | LKFT |
|---|---|---|
| Relative Strength Index (RSI) | 53.35 | 53.89 |
| Support Level | $8.82 | $28.28 |
| Resistance Level | $9.63 | $30.00 |
| Average True Range (ATR) | 0.15 | 0.63 |
| MACD | 0.01 | 0.06 |
| Stochastic Oscillator | 66.67 | 62.84 |
Global Net Lease Inc is a real estate investment trust that manages a globally diversified portfolio of commercial real estate properties. The company is engaged in the ownership, management, operation, lease, acquisition, investment, and sale of the portfolio assets. Its segments include Industrial & Distribution, Retail, and Office. The company derives maximum revenue from the Industrial and Distribution segment. The company geographically operates in the United States, the United Kingdom, Canada, and Europe.
Lakefront Biotherapeutics NV a biopharmaceutical company committed to improving the lives of people with severe diseases. It focuses on delivering medicines with transformational impact for patients by accelerating life-changing science and innovation in areas of high unmet need. Its pipelines includes GLPG3667, GLPG5101, and GLPG5301.